KalVista Pharmaceuticals, Inc.【KALV】 減価償却費の推移

機能の使い方
(単位:ドル) 減価償却費 前年比(%)
1Q26 252,000 +12.5%
4Q25 261,000 +28.6%
3Q25 229,000 +10.6%
2Q25 227,000 +15.2%
1Q25 224,000 +16.1%
4Q24 203,000 +8.0%
3Q24 207,000 +4.0%
2Q24 197,000 +13.9%
1Q24 193,000 +22.2%
4Q23 188,000 +20.5%
3Q23 199,000 +33.6%
2Q23 173,000 +36.2%
1Q23 158,000 +19.7%
4Q22 156,000 +11.4%
3Q22 149,000 +9.6%
2Q22 127,000 -4.5%
1Q22 132,000 +3.1%
4Q21 140,000 +7.7%
3Q21 136,000 +1.5%
2Q21 133,000 +4.7%
1Q21 128,000 +5.8%
4Q20 130,000 +6.6%
3Q20 134,000 +30.1%
2Q20 127,000 +23.3%
1Q20 121,000 +142.0%
4Q19 122,000 +139.2%
3Q19 103,000 +106.0%
2Q19 103,000 +119.1%
1Q19 50,000 +56.3%
4Q18 51,000 -
3Q18 50,000 -
2Q18 47,000 -
1Q18 32,000 -
3Q16 0 -100.0%
2Q16 0 -100.0%
1Q16 34,000 +9.7%
4Q15 35,000 -
3Q15 33,000 -
2Q15 34,000 -
1Q15 31,000 -